logo-loader
RNS
Beazley PLC

Societe Generale SA - Form 8.3 - Beazley plc

RNS Number : 1733B
Societe Generale SA
20 April 2026
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a)  Full name of discloser:

SOCIETE GENERALE SA

(b)  Owner or controller of interests and short positions disclosed, if different from 1(a):

       The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.


(c)  Name of offeror/offeree in relation to whose relevant securities this form relates:

       Use a separate form for each offeror/offeree

Beazley plc

(d)  If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:


(e)  Date position held/dealing undertaken:

       For an opening position disclosure, state the latest practicable date prior to the disclosure

17/04/2026

(f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

       If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

5p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1)  Relevant securities owned and/or controlled:

27,058,588

4.50

12,359,994

2.06

(2)  Cash-settled derivatives:

 

12,319,478

2.05

25,013,364

4.16

(3)  Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

TOTAL:

39,378,066

6.55

37,373,358

6.21

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)        Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

GBP

5p ordinary

Purchase

47

12.74

5p ordinary

Purchase

74

12.74

5p ordinary

Purchase

122

12.74

5p ordinary

Purchase

607

12.74

5p ordinary

Purchase

607

12.74

5p ordinary

Purchase

607

12.74

5p ordinary

Purchase

607

12.74

5p ordinary

Purchase

607

12.74

5p ordinary

Purchase

607

12.74

5p ordinary

Purchase

607

12.74

5p ordinary

Purchase

607

12.74

5p ordinary

Purchase

607

12.74

5p ordinary

Purchase

194

12.74

5p ordinary

Purchase

194

12.74

5p ordinary

Purchase

219

12.74

5p ordinary

Purchase

267

12.74

5p ordinary

Purchase

19

12.7425

5p ordinary

Purchase

44

12.7375

5p ordinary

Purchase

47

12.7375

5p ordinary

Purchase

49

12.7375

5p ordinary

Purchase

55

12.7375

5p ordinary

Purchase

57

12.7375

5p ordinary

Purchase

59

12.7375

5p ordinary

Purchase

59

12.7375

5p ordinary

Purchase

60

12.7375

5p ordinary

Purchase

62

12.7375

5p ordinary

Purchase

62

12.7375

5p ordinary

Purchase

62

12.7375

5p ordinary

Purchase

66

12.7375

5p ordinary

Purchase

69

12.7375

5p ordinary

Purchase

115

12.7375

5p ordinary

Purchase

134

12.7375

5p ordinary

Purchase

143

12.7375

5p ordinary

Purchase

78

12.74

5p ordinary

Purchase

120

12.74

5p ordinary

Purchase

124

12.74

5p ordinary

Purchase

152

12.745

5p ordinary

Purchase

172

12.74

5p ordinary

Purchase

183

12.74

5p ordinary

Purchase

184

12.74

5p ordinary

Purchase

185

12.74

5p ordinary

Purchase

189

12.74

5p ordinary

Purchase

191

12.74

5p ordinary

Purchase

199

12.74

5p ordinary

Purchase

206

12.74

5p ordinary

Purchase

234

12.74

5p ordinary

Purchase

276

12.74

5p ordinary

Purchase

287

12.74

5p ordinary

Purchase

302

12.74

5p ordinary

Purchase

357

12.74

5p ordinary

Purchase

481

12.74

5p ordinary

Purchase

538

12.74

5p ordinary

Purchase

544

12.74

5p ordinary

Purchase

839

12.74

5p ordinary

Purchase

1,053

12.74

5p ordinary

Purchase

1,117

12.74

5p ordinary

Purchase

2,017

12.74

5p ordinary

Purchase

2,777

12.74

5p ordinary

Purchase

409

12.74

5p ordinary

Purchase

582

12.735

5p ordinary

Purchase

971

12.74

5p ordinary

Purchase

681

12.74

5p ordinary

Purchase

2,545

12.74

5p ordinary

Purchase

72

12.74

5p ordinary

Purchase

72

12.74

5p ordinary

Purchase

72

12.74

5p ordinary

Purchase

90

12.74

5p ordinary

Purchase

82

12.74

5p ordinary

Purchase

71

12.74

5p ordinary

Purchase

69

12.74

5p ordinary

Purchase

68

12.74

5p ordinary

Purchase

124

12.74

5p ordinary

Purchase

15

12.74

5p ordinary

Purchase

101

12.74

5p ordinary

Purchase

69

12.74

5p ordinary

Purchase

65

12.74

5p ordinary

Purchase

66

12.74

5p ordinary

Purchase

1

12.74

5p ordinary

Purchase

68

12.74

5p ordinary

Purchase

70

12.74

5p ordinary

Purchase

91

12.74

5p ordinary

Purchase

73

12.74

5p ordinary

Purchase

108

12.74

5p ordinary

Purchase

113

12.74

5p ordinary

Purchase

3

12.74

5p ordinary

Purchase

78

12.74

5p ordinary

Purchase

72

12.74

5p ordinary

Purchase

113

12.74

5p ordinary

Purchase

95

12.74

5p ordinary

Purchase

68

12.74

5p ordinary

Purchase

66

12.74

5p ordinary

Purchase

77

12.74

5p ordinary

Purchase

124

12.74

5p ordinary

Purchase

64

12.74

5p ordinary

Purchase

112

12.74

5p ordinary

Purchase

71

12.74

5p ordinary

Purchase

64

12.74

5p ordinary

Purchase

128

12.74

5p ordinary

Purchase

105

12.74

5p ordinary

Purchase

5

12.74

5p ordinary

Purchase

126

12.74

5p ordinary

Purchase

75

12.74

5p ordinary

Purchase

83

12.74

5p ordinary

Purchase

131

12.74

5p ordinary

Purchase

64

12.74

5p ordinary

Purchase

68

12.74

5p ordinary

Purchase

67

12.74

5p ordinary

Purchase

3

12.74

5p ordinary

Purchase

71

12.74

5p ordinary

Purchase

80

12.74

5p ordinary

Purchase

123

12.74

5p ordinary

Purchase

116

12.74

5p ordinary

Purchase

93

12.74

5p ordinary

Purchase

124

12.74

5p ordinary

Purchase

107

12.74

5p ordinary

Purchase

113

12.74

5p ordinary

Purchase

71

12.74

5p ordinary

Purchase

67

12.74

5p ordinary

Purchase

65

12.74

5p ordinary

Purchase

13

12.74

5p ordinary

Purchase

126

12.74

5p ordinary

Purchase

112

12.74

5p ordinary

Purchase

100

12.74

5p ordinary

Purchase

73

12.74

5p ordinary

Purchase

74

12.74

5p ordinary

Purchase

67

12.74

5p ordinary

Purchase

68

12.74

5p ordinary

Purchase

71

12.74

5p ordinary

Purchase

78

12.74

5p ordinary

Purchase

78

12.74

5p ordinary

Purchase

136

12.74

5p ordinary

Purchase

128

12.74

5p ordinary

Purchase

71

12.74

5p ordinary

Purchase

127

12.74

5p ordinary

Purchase

75

12.74

5p ordinary

Purchase

66

12.74

5p ordinary

Purchase

124

12.74

5p ordinary

Purchase

112

12.74

5p ordinary

Purchase

65

12.74

5p ordinary

Purchase

59

12.74

5p ordinary

Purchase

64

12.74

5p ordinary

Purchase

74

12.74

5p ordinary

Purchase

67

12.74

5p ordinary

Purchase

78

12.74

5p ordinary

Purchase

67

12.74

5p ordinary

Sale

3,364

12.735

5p ordinary

Sale

2

12.74

5p ordinary

Sale

4

12.74

5p ordinary

Sale

12

12.74

5p ordinary

Sale

14

12.74

5p ordinary

Sale

119

12.74

5p ordinary

Sale

134

12.74

5p ordinary

Sale

246

12.74

5p ordinary

Sale

347

12.74

5p ordinary

Sale

607

12.74

5p ordinary

Sale

628

12.74

5p ordinary

Sale

749

12.74

5p ordinary

Sale

1,067

12.74

5p ordinary

Sale

1,095

12.74

5p ordinary

Sale

1,214

12.74

5p ordinary

Sale

1,214

12.74

5p ordinary

Sale

1,789

12.74

5p ordinary

Sale

2,295

12.74

5p ordinary

Sale

2,429

12.74

5p ordinary

Sale

2,429

12.74

5p ordinary

Sale

2,429

12.74

5p ordinary

Sale

2,429

12.74

5p ordinary

Sale

2,429

12.74

5p ordinary

Sale

2,429

12.74

5p ordinary

Sale

2,429

12.74

5p ordinary

Sale

2,429

12.74

5p ordinary

Sale

2,429

12.74

5p ordinary

Sale

107

12.74

5p ordinary

Sale

299

12.74

5p ordinary

Sale

304

12.74

5p ordinary

Sale

314

12.74

5p ordinary

Sale

501

12.74

5p ordinary

Sale

582

12.74

5p ordinary

Sale

632

12.74

5p ordinary

Sale

666

12.74

5p ordinary

Sale

670

12.74

5p ordinary

Sale

794

12.74

5p ordinary

Sale

797

12.74

5p ordinary

Sale

799

12.74

5p ordinary

Sale

1,014

12.74

5p ordinary

Sale

1,024

12.74

5p ordinary

Sale

1,405

12.74

5p ordinary

Sale

1,709

12.74

5p ordinary

Sale

1,797

12.74

5p ordinary

Sale

2,322

12.74

5p ordinary

Sale

2,429

12.74

5p ordinary

Sale

681

12.74

5p ordinary

Sale

2,545

12.74

 

 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

GBP

5p ordinary

CFD

Reducing a short position

3,364

12.735

 

 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c)        Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

20/04/2026

Contact name:

Paul Jenkins

Telephone number*:

+44 20 7676 6969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETURVURNKUSUAR
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

6 min read